https://www.selleckchem.com/pr....oducts/durvalumab.ht
The aim of the current study was to search the effect of COVID-19 restriction on developmental dysplasia of hip (DDH) screening. We retrospectively reviewed the patients who brought to DDH screening in April-May and June-July 2020 and compared with the same period of 2019. We recorded age, gender, DDH type and risk factors of the patients. The number of patients taken for DDH screening was 430 and 400 in April-May 2019 and June-July 2019, respectively. In 2020, the number of patients taken for DDH screening was 159 and 776 in the sam
Like
Comment
Share
